|
|
||||||||
Papers In Press, published online ahead of print January 16, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Facultad de Medicina, Universidad Complutense, Madrid 28040
Corresponding Author: piedras3{at}med.ucm.es
The prostaglandin J2 derivate 15 deoxy-delta-12,14-PGJ2 (15d-PGJ2) is a very active compound with important effects on inflammation, apoptosis, and cell growth processes. To exert this broad range of effects, 15d-PGJ2 binds and alters the activity of diverse proteins, which consequently are postulated to be mediators of its action. Among them are the transcription factors PPARgamma and NF-kB, thought to play an essential role in the anti-tumorigenic and anti-inflammatory actions of 15d-PGJ2. Here, we show that 15d-PGJ2, at micromolar concentrations, efficiently blocks state 3 oxygen consumption in intact non-synaptic mitochondria isolated from rat cerebral cortex. This effect is due to the inhibition by this prostaglandin of the activity of the enzyme NADH-ubiquinone reductase (complex I) of the mitochondrial respiratory chain. In addition to this, 15d-PGJ2 dramatically increases the rate of ROS generation by complex I. The inhibition by 15d-PGJ2 of complex I activity was abolished by dithiothreitol, which rises the possibility that adduct formation with a critical component of complex I accounts for the inhibitory effect of this prostaglandin. These results clearly identify mitochondrial complex I as a new target for 15d-PGJ2 actions.
Revised on December 21, 2004
Accepted on January 10, 2005
The mitochondrial respiratory complex I is a target for 15 deoxy-delta-12,14-PGJ2 (15d-PGJ2) action
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
E.-H. Kim, H.-K. Na, D.-H. Kim, S.-A. Park, H.-N. Kim, N.-Y. Song, and Y.-J. Surh 15-Deoxy-{Delta}12,14-prostaglandin J2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells: a potential role of ROS Carcinogenesis, April 1, 2008; 29(4): 688 - 695. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fosslien Cancer Morphogenesis: Role of Mitochondrial Failure Ann. Clin. Lab. Sci., January 1, 2008; 38(4): 307 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Bao, C. J. Zhao, J. Y. Li, H. Zhang, and Ch. Wu A Comparison of Mitochondrial Respiratory Function of Tibet Chicken and Silky Chicken Embryonic Brain Poult. Sci., October 1, 2007; 86(10): 2210 - 2215. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Brookes, K. Morse, D. Ray, A. Tompkins, S. M. Young, S. Hilchey, S. Salim, M. Konopleva, M. Andreeff, R. Phipps, et al. The Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid and Its Derivatives Elicit Human Lymphoid Cell Apoptosis through a Novel Pathway Involving the Unregulated Mitochondrial Permeability Transition Pore Cancer Res., February 15, 2007; 67(4): 1793 - 1802. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sandig, J. E. Pease, and I. Sabroe Contrary prostaglandins: the opposing roles of PGD2 and its metabolites in leukocyte function J. Leukoc. Biol., February 1, 2007; 81(2): 372 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, V. M. Aris, K. D. Ogburn, P. Soteropoulos, and M. E. Figueiredo-Pereira Prostaglandin J2 Alters Pro-survival and Pro-death Gene Expression Patterns and 26 S Proteasome Assembly in Human Neuroblastoma Cells J. Biol. Chem., July 28, 2006; 281(30): 21377 - 21386. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Landar, J. W. Zmijewski, D. A. Dickinson, C. Le Goffe, M. S. Johnson, G. L. Milne, G. Zanoni, G. Vidari, J. D. Morrow, and V. M. Darley-Usmar Interaction of electrophilic lipid oxidation products with mitochondria in endothelial cells and formation of reactive oxygen species Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1777 - H1787. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Peraza, A. D. Burdick, H. E. Marin, F. J. Gonzalez, and J. M. Peters The Toxicology of Ligands for Peroxisome Proliferator-Activated Receptors (PPAR) Toxicol. Sci., April 1, 2006; 90(2): 269 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fosslien Cardiovascular Complications of Non-Steroidal Anti-Inflammatory Drugs Ann. Clin. Lab. Sci., October 1, 2005; 35(4): 347 - 385. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |